333 related articles for article (PubMed ID: 15165132)
61. Design, synthesis and biological evaluation of a macrocyclic discodermolide/dictyostatin hybrid.
Paterson I; Gardner NM
Chem Commun (Camb); 2007 Jan; (1):49-51. PubMed ID: 17279257
[TBL] [Abstract][Full Text] [Related]
62. Synthesis and cytotoxic activity of gamma-aryl substituted alpha-alkylidene-gamma-lactones and alpha-alkylidene-gamma-lactams.
Albrecht A; Koszuk JF; Modranka J; Rózalski M; Krajewska U; Janecka A; Studzian K; Janecki T
Bioorg Med Chem; 2008 May; 16(9):4872-82. PubMed ID: 18396404
[TBL] [Abstract][Full Text] [Related]
63. [Natural anti-tumor compounds with activity of promoting microtubule assembly].
Li YZ; Hu W; Zhou L
Yao Xue Xue Bao; 2001 Feb; 36(2):155-60. PubMed ID: 12579888
[No Abstract] [Full Text] [Related]
64. Synthesis of (+)-discodermolide by catalytic stereoselective borylation reactions.
Yu Z; Ely RJ; Morken JP
Angew Chem Int Ed Engl; 2014 Sep; 53(36):9632-6. PubMed ID: 25045037
[TBL] [Abstract][Full Text] [Related]
65. Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs.
Romero M; Renard P; Caignard DH; Atassi G; Solans X; Constans P; Bailly C; Pujol MD
J Med Chem; 2007 Jan; 50(2):294-307. PubMed ID: 17228871
[TBL] [Abstract][Full Text] [Related]
66. Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation.
Honore S; Kamath K; Braguer D; Wilson L; Briand C; Jordan MA
Mol Cancer Ther; 2003 Dec; 2(12):1303-11. PubMed ID: 14707271
[TBL] [Abstract][Full Text] [Related]
67. The clinical development of new mitotic inhibitors that stabilize the microtubule.
Mani S; Macapinlac M; Goel S; Verdier-Pinard D; Fojo T; Rothenberg M; Colevas D
Anticancer Drugs; 2004 Jul; 15(6):553-8. PubMed ID: 15205596
[TBL] [Abstract][Full Text] [Related]
68. The bound conformation of microtubule-stabilizing agents: NMR insights into the bioactive 3D structure of discodermolide and dictyostatin.
Canales A; Matesanz R; Gardner NM; Andreu JM; Paterson I; Díaz JF; Jiménez-Barbero J
Chemistry; 2008; 14(25):7557-69. PubMed ID: 18449868
[TBL] [Abstract][Full Text] [Related]
69. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
Congiu C; Cocco MT; Onnis V
Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978
[TBL] [Abstract][Full Text] [Related]
70. The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence.
Klein LE; Freeze BS; Smith AB; Horwitz SB
Cell Cycle; 2005 Mar; 4(3):501-7. PubMed ID: 15711127
[TBL] [Abstract][Full Text] [Related]
71. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide.
Gertsch J; Meier S; Müller M; Altmann KH
Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273
[TBL] [Abstract][Full Text] [Related]
72. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.
Chen JG; Horwitz SB
Cancer Res; 2002 Apr; 62(7):1935-8. PubMed ID: 11929805
[TBL] [Abstract][Full Text] [Related]
73. Novel antitumor agent family of 1H-benzo[c,d]indol-2-one with flexible basic side chains: synthesis and biological evaluation.
Yin H; Xu Y; Qian X
Bioorg Med Chem; 2007 Feb; 15(3):1356-62. PubMed ID: 17129733
[TBL] [Abstract][Full Text] [Related]
74. Synthesis, conformational analysis, and cytotoxicity of new analogues of the natural cyclodepsipeptide jaspamide.
Terracciano S; Bruno I; Bifulco G; Copper JE; Smith CD; Gomez-Paloma L; Riccio R
J Nat Prod; 2004 Aug; 67(8):1325-31. PubMed ID: 15332850
[TBL] [Abstract][Full Text] [Related]
75. Human liver microsomal metabolism of (+)-discodermolide.
Fan Y; Schreiber EM; Day BW
J Nat Prod; 2009 Oct; 72(10):1748-54. PubMed ID: 19775091
[TBL] [Abstract][Full Text] [Related]
76. Hemisynthetic secofriedelane triterpenes with inhibitory activity against the growth of human tumor cell lines in vitro.
Moiteiro C; Manta C; Justino F; Tavares R; Curto MJ; Pedro M; Nascimento MS; Pinto M
J Nat Prod; 2004 Jul; 67(7):1193-6. PubMed ID: 15270581
[TBL] [Abstract][Full Text] [Related]
77. Gamma-lactones alpha,beta- and beta,gamma-fused to carbocycles as novel antiproliferative drugs.
León LG; Machín RP; Rodríguez CM; Ravelo JL; Martín VS; Padrón JM
Bioorg Med Chem Lett; 2008 Oct; 18(19):5171-3. PubMed ID: 18789684
[TBL] [Abstract][Full Text] [Related]
78. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.
Martello LA; McDaid HM; Regl DL; Yang CP; Meng D; Pettus TR; Kaufman MD; Arimoto H; Danishefsky SJ; Smith AB; Horwitz SB
Clin Cancer Res; 2000 May; 6(5):1978-87. PubMed ID: 10815923
[TBL] [Abstract][Full Text] [Related]
79. Synthesis, cytotoxicity, and structure-activity relationship (SAR) studies of andrographolide analogues as anti-cancer agent.
Das B; Chowdhury C; Kumar D; Sen R; Roy R; Das P; Chatterjee M
Bioorg Med Chem Lett; 2010 Dec; 20(23):6947-50. PubMed ID: 20974534
[TBL] [Abstract][Full Text] [Related]
80. Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors.
Itoh Y; Suzuki T; Kouketsu A; Suzuki N; Maeda S; Yoshida M; Nakagawa H; Miyata N
J Med Chem; 2007 Nov; 50(22):5425-38. PubMed ID: 17929798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
